%PDF-1.6
%
1 0 obj
<<
/Lang (en)
/MarkInfo <<
/Marked true
>>
/Metadata 2 0 R
/Outlines 3 0 R
/PageLayout /OneColumn
/PageMode /UseOutlines
/Pages 4 0 R
/StructTreeRoot 5 0 R
/Type /Catalog
/ViewerPreferences <<
/DisplayDocTitle true
>>
>>
endobj
6 0 obj
<<
/Author (Gemeinsamer Bundesausschuss/Federal Joint Committee)
/Category (Nr. XXX \(S. XX XXX\))
/Comments (Anlage 1 zu TOP 8.1.2)
/Company (Gemeinsamer Bundesausschuss, \(www.g-ba.de\))
/CreationDate (D:20210819083942+02'00')
/Creator <4163726F626174205044464D616B65722032302066FC7220576F7264>
/Keywords <416E6E6578205849492085205265736F6C7574696F6E73206F6E207468652042656E65666974204173736573736D656E74206F66204D65646963696E616C2050726F64756374732077697468204E65772041637469766520496E6772656469656E7473204163636F7264696E6720746F2053656374696F6E20333561205347422056202D20456E7472656374696E6962>
/ModDate (D:20210826133649+02'00')
/Producer (Adobe PDF Library 20.4.54)
/SourceModified (D:20210819063929)
/Subject (Pharmaceuticals Directive \(AM RL\):)
/Title (Resolution)
>>
endobj
2 0 obj
<<
/Length 4881
/Subtype /XML
/Type /Metadata
>>
stream
2021-08-26T13:36:49+02:00
2021-08-19T08:39:42+02:00
2021-08-26T13:36:49+02:00
Acrobat PDFMaker 20 für Word
uuid:f2e7a236-de73-418c-8070-7dac59fe09a8
uuid:741a300f-4be3-40b2-9f53-d3408f7e5728
16
application/pdf
Resolution
Pharmaceuticals Directive (AM RL):
Gemeinsamer Bundesausschuss/Federal Joint Committee
www.g-ba.de
Annex XII – Resolutions on the Benefit Assessment of Medicinal Products with New Active Ingredients According to Section 35a SGB V - Entrectinib
Adobe PDF Library 20.4.54
Annex XII – Resolutions on the Benefit Assessment of Medicinal Products with New Active Ingredients According to Section 35a SGB V - Entrectinib
D:20210819063929
Gemeinsamer Bundesausschuss, (www.g-ba.de)
Anlage 1 zu TOP 8.1.2
Nr. XXX (S. XX XXX)
Arzneimittel-Richtlinie (AM-RL):
endstream
endobj
3 0 obj
<<
/Count 4
/First 7 0 R
/Last 8 0 R
/Type /Outlines
>>
endobj
4 0 obj
<<
/Count 3
/Kids [9 0 R 10 0 R 11 0 R]
/Type /Pages
>>
endobj
5 0 obj
<<
/K 12 0 R
/ParentTree 13 0 R
/ParentTreeNextKey 5
/RoleMap 14 0 R
/Type /StructTreeRoot
>>
endobj
7 0 obj
<<
/A 15 0 R
/Next 16 0 R
/Parent 3 0 R
/Title (1. Additional benefit of the medicinal product in relation to the appropriate comparator therapy)
>>
endobj
8 0 obj
<<
/A 17 0 R
/Parent 3 0 R
/Prev 18 0 R
/Title (4. Treatment costs)
>>
endobj
9 0 obj
<<
/Contents [19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R]
/CropBox [0.0 0.0 595.2 841.6]
/MediaBox [0.0 0.0 595.2 841.6]
/Parent 4 0 R
/Resources <<
/Font <<
/C2_0 28 0 R
/TT0 29 0 R
/TT1 30 0 R
/TT2 31 0 R
>>
/XObject <<
/OL1 32 0 R
>>
>>
/Rotate 0
/StructParents 0
/Tabs /S
/Type /Page
>>
endobj
10 0 obj
<<
/Annots [33 0 R 34 0 R]
/Contents [35 0 R 36 0 R]
/CropBox [0.0 0.0 595.2 841.6]
/MediaBox [0.0 0.0 595.2 841.6]
/Parent 4 0 R
/Resources <<
/Font <<
/C2_0 37 0 R
/C2_1 28 0 R
/TT0 29 0 R
/TT1 38 0 R
/TT2 30 0 R
/TT3 39 0 R
>>
/XObject <<
/OL1 32 0 R
>>
>>
/Rotate 0
/StructParents 1
/Tabs /S
/Type /Page
>>
endobj
11 0 obj
<<
/Contents [40 0 R 41 0 R]
/CropBox [0.0 0.0 595.2 841.6]
/MediaBox [0.0 0.0 595.2 841.6]
/Parent 4 0 R
/Resources <<
/Font <<
/C2_0 37 0 R
/TT0 38 0 R
/TT1 29 0 R
/TT2 30 0 R
>>
/XObject <<
/OL1 32 0 R
>>
>>
/Rotate 0
/StructParents 4
/Tabs /S
/Type /Page
>>
endobj
12 0 obj
<<
/K [42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R
52 0 R 53 0 R 54 0 R 55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R 61 0 R
62 0 R 63 0 R 64 0 R 65 0 R 66 0 R 67 0 R 68 0 R 69 0 R 70 0 R 71 0 R
72 0 R 73 0 R 74 0 R 75 0 R 76 0 R 77 0 R 78 0 R 79 0 R 80 0 R 81 0 R
82 0 R 83 0 R 84 0 R 85 0 R 86 0 R 87 0 R 88 0 R 89 0 R 90 0 R]
/P 5 0 R
/S /Sect
>>
endobj
13 0 obj
<<
/Nums [0 [42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R
52 0 R null null 91 0 R null null null 92 0 R null null
null 93 0 R null null 54 0 R 55 0 R null null 94 0 R null
null null 95 0 R null null null 96 0 R null null 57 0 R
58 0 R 59 0 R 60 0 R 61 0 R null null 97 0 R null null 63 0 R
null null 98 0 R null null 65 0 R]
1 [66 0 R 67 0 R 68 0 R 69 0 R 70 0 R 71 0 R 72 0 R null 99 0 R null
100 0 R null null 101 0 R null 102 0 R null 103 0 R null null
104 0 R null 105 0 R null 106 0 R null 107 0 R null 108 0 R 109 0 R
110 0 R null 111 0 R null 112 0 R 113 0 R 114 0 R null 115 0 R null
116 0 R 117 0 R 118 0 R null 119 0 R null 120 0 R 121 0 R 122 0 R null
123 0 R null 124 0 R null 125 0 R null 126 0 R null 127 0 R null
128 0 R null 129 0 R null 130 0 R null 131 0 R 74 0 R 75 0 R 76 0 R
77 0 R 78 0 R null 132 0 R 79 0 R 80 0 R]
2 132 0 R 3 132 0 R 4 [81 0 R 82 0 R 83 0 R 84 0 R 85 0 R 86 0 R null 133 0 R null 134 0 R
null null 135 0 R null 136 0 R null 137 0 R null 138 0 R null
139 0 R null 140 0 R null 141 0 R null 142 0 R 143 0 R null 144 0 R
null 145 0 R 146 0 R null 147 0 R null 148 0 R null 149 0 R null
150 0 R null 151 0 R 152 0 R null 153 0 R null 154 0 R 155 0 R 88 0 R
89 0 R 90 0 R]
]
>>
endobj
14 0 obj
<<
/Annotation /Span
/Artifact /P
/Bibliography /BibEntry
/Chart /Figure
/Diagram /Figure
/DropCap /Figure
/Endnote /Note
/Footnote /Note
/InlineShape /Figure
/Outline /Span
/Strikeout /Span
/Subscript /Span
/Superscript /Span
/TextBox /Art
/Underline /Span
>>
endobj
15 0 obj
<<
/D [9 0 R /XYZ 69 330 0.0]
/S /GoTo
>>
endobj
16 0 obj
<<
/A 156 0 R
/Next 18 0 R
/Parent 3 0 R
/Prev 7 0 R
/Title (2. Number of patients or demarcation of patient groups eligible for treatment)
>>
endobj
17 0 obj
<<
/D [11 0 R /XYZ 69 689 0.0]
/S /GoTo
>>
endobj
18 0 obj
<<
/A 157 0 R
/Next 8 0 R
/Parent 3 0 R
/Prev 16 0 R
/Title (3. Requirements for a quality-assured application)
>>
endobj
19 0 obj
<<
/Length 57
/Filter /FlateDecode
>>
stream
x+*23P0b[0475
s}\ mq
endstream
endobj
20 0 obj
<<
/Length 2553
/Filter /FlateDecode
>>
stream
HTWKe
U
Y_Al$H-{l?*}N.#S,Ro_Ϗ?~/??>g,ms SJl1z#
=ciO03hO Bj||+.3X9\de%Gۅ#D!/et{i{[i$ZTխ.[t5ֆ'(Ek"Jh^Vޱt=aiP/6P2E:bipǪu͕FdjqH#R(ReA&#`F
_[Z]˔kIۻ`oU,a;0l_m"P28RwJ-aØ܆98p$PHѕAS?#zEq:R`$#8HIXJ 3B6
S7]k\_Wʐ8PSdsv2$ԎM` ؗj\$N|9^+V
Ba 1P91sUCrM&WW]Qf!Z>䈀r%&\V<()Y2DnKƭAt&J.R%2)"ܶMeMQ'g@&$kYi dT@i=!Uym!ȥcq{
H$/i{Px6%O U
Ƥ*AH=]P&YXM_?r?(f;
r3tNfqxʪUfZ#CJ$28`2Щkj"I'QCAwn-3ԥ/MǬ+2MD{]oXl%/b-z2 _ :srݰ+L7Qy!Vۙr|1Kd)i 9ys0]1O{-kWutblVR
ʳ#9D-87ܝ <J B6[pQ s;{Jn)Gm.mvb}q|V,)A3qcr 8mٞVZHW&w݆D2Eu!qG.p+^ή \0!Ύ~ζ5H
%d.,VSJYPKYDA2YDN7(Z,zfЕƭ#eEsN|#~^{Fl(R Kxҕe/i^[bz[8moHc+Oi6ZʻԚߍ|U%\i;^Iʽ5 4X i4S1n2:nsվ6SyDml kBW6d池rPo}N.v$cm1HSÂk
zz²~!K %h͟ܩ7ԊMʺzZ'b,txUNv"⭥C`"tlރZ77uD?x!]ӎw~ms %q/jF-ovG5]E;~_w#z{NO^16~}
IwY}e{tyH-|kyQdt~a~}KѝW0o6
-2]8L~"a坹ΗH]xW(_>vQ"`O|?u
ڊV>#q4>6k0bkL]
;SxbVR)"zEKePC=2hJ'cSD.y2qC>xD{')hSm}qFZs9FF_ `0";Vkn<-:8u}.@J
i`>+a\Ve
?Wo[ ޙ,4tNw0Lp@1^
Z8BLݛ5`xI1VIrCW
L]h ctW;\[Q0A̺7.v2J{0"u
BӘ먠t6,J2BLF9lMl@ŋx-n0uÎD;^:K2Osiw).!Z@Bӑ5H
v+v: , <0(},>jQ gtM'F|u`bUu
fGaG
dk^(2W^3My-5UOޕ=u,h5k@߷gMiь
t&\[-H~W?aY'U}w_)b-~<[+rXmJGlSjpX
<1_f cJ{VQRGl
#Ose@*?y,SCL;T[GEk3mmft/h[*O|Cgס}^Q|x?0 ŞP
endstream
endobj
21 0 obj
<<
/Length 2526
/Filter /FlateDecode
>>
stream
HTWK$)Hc8|yߘ ̚iR)y,S0ŁѮͿef .h^6:
dwsȭ wU\o7W\c-Feuh3]^Z~yJ- 1|&
Tݳ{3gr̀D(&j[$jnq/~9^C_9bcreNȻpN*(}H?:!xu}vt܉=>Ahhdžc@B3pB3Ea
L@wxRswk/{;8sEDIc3M}fzT|rHpnRtdwBg;wsރ`Uk2ԐPe.0!:pCM~F FȈ4n֒E0@1()iS
xS
zF=wV d^]@`zL)NRI5bܲieW 29EO>",uJqz)M&1~2~zB5n4J&4O}2^7+]U,0ZwϹU;ȪN
LiC@{&YFIk3#sTp2ʡc2gax>~<5Dt3^N|}:W˞绶/{=
8q~}>><&lgpw9F'L4*,~FQyRVZb/F5 ƭ?ݘ̷6-Acj0#۾sg)iYƲUPzTX@kGP+(9m*Tdu?UF^H8rNUE`-P 3S&iVua'bUPGV
ܫgb~ŏN5U}AS+Qvr~r Q@ҷn@]8
'.id=o>{R
XCLu}]^hXm# z4lH:9G.[ŭ:Q+iDE`(jqSWpY!
U:{eOYnciRfɂǼY4QO?7yGE?z|?% q_vCCYJ(Wv|?*l6KMF7v~
Vu\x:T;c.M=I I ;Ll="4;9>:uУv6dA`X)o$%=U,&y"QR0avP3|W)cSM!eӥx2T>g(*&dua(F[~d{5ghE4
QtL8뉌Ӎz6*
պ^z%K C|RX#4OO(n(ht(KR_MFiZG,-+BA0=;
/;.r߱8Iq5s"U9gQq|guW3{||TӥcfX҉n[fu*eapcw^GejnYXpkM9AqfGȡ1rݭ9'r8n:٠Nl/.mggϽ#UEpoPNbt0`0=:ՆvoԀ^+7սy7Oz'~2?:w7T9' %Z]|2]2[Ef^1/:ā[s}OEz/4R+7ѩCFҙ/KauEZIHXU6{ogxo]
MdX%9V~jnim1PL \$хucåaΟO?"h;H~UTPq>%4ܭ\~Z/{}My"q515%~5O]@EdZE5l v"T}m>})_|&o u|z,̝'/ l$(lgBo '{̈t|d`#av'#hz60
o#Cj[*IraT\ 0 _R
endstream
endobj
22 0 obj
<<
/Length 2040
/Filter /FlateDecode
>>
stream
HlWI-&goPQ)Pli?*J?_9>ՄZǏ iZRfb8}FNCχX&2ՏMu9]:=}3lMȬ{hgNG
xe]vsrͯ.")
W]U*3p
F&=2$gi^JĤ*}e3ޙ)V9Ѿ=/\bjϜyZk+muXKy~쓌X"xa2#*З^7hNv1X9#l"}lr|!pemPwI#(,IYL Oeԃ&hCԠrՇ=0zp8쳖{o,," ~ޕrƐu
#߾aAe&!w$|>0!!^`J_i3"cЂHy> lI9yhݣIcQsy
J6Zpà "Q{PaEX`XE3r9k7Ɯ3m>y(MolQ-{K%آ _99.ceۙ2L3)Z8[tgrT
wOfE 5!MŚF8wJ2F~"ب-3LإLch2Faű`cL
AkT/lH5fhf55 ffqf8kFTPg͘#PzL\>\R)^ZZSKܣt:[n.ܝ%4ޜΈ3nPӨ OFrӨ|89D~:no[itj H<4O:EFtv9\E:+`VIJ\1/萭,3X#+2%?81q^K-8=[@J*- a/#Jˈܲ r˲ND.
1a*Pu_daf]$q7n Ů41-ݯ|Ger;x\h?K
V{ju=]Z+4[dJP*X(2!~}_IB\LEfvK^ȍVZ6F͆JBCi#Y̒[.*USm4N.̤֜3QoSf)cwv$:bD#f{ioO#Oc@m4!omw*B;.g%)q$Z,akp+#)4#~9Fsߠ՜\,E>FQ6zVED(C0XZпp` 3OƆ'E'#P@(K>wFD@Ž⏠86(C$!92M